Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD4+ and CD8+ T cell–dependent antiviral immunity requires STIM1 and STIM2
Patrick J. Shaw, Carl Weidinger, Martin Vaeth, Kevin Luethy, Susan M. Kaech, Stefan Feske
Patrick J. Shaw, Carl Weidinger, Martin Vaeth, Kevin Luethy, Susan M. Kaech, Stefan Feske
View: Text | PDF
Research Article

CD4+ and CD8+ T cell–dependent antiviral immunity requires STIM1 and STIM2

  • Text
  • PDF
Abstract

Calcium signaling is critical for lymphocyte function, and intracellular Ca2+ concentrations are regulated by store-operated Ca2+ entry (SOCE) through Ca2+ release–activated Ca2+ (CRAC) channels. In patients, loss-of-function mutations in CRAC channel components ORAI1 and STIM1 abolish SOCE and are associated with recurrent and chronic viral infections. Here, using mice with conditional deletion of Stim1 and its homolog Stim2 in T cells, we determined that both components are required for the maintenance of virus-specific memory CD8+ T cells and recall responses following secondary infection. In the absence of STIM1 and STIM2, acute viral infections became chronic. Early during infection, STIM1 and STIM2 were required for the differentiation of naive CD8+ T cells into fully functional cytolytic effector cells and mediated the production of cytokines and prevented cellular exhaustion in viral-specific CD8+ effector T cells. Importantly, memory and recall responses by CD8+ T cells required expression of STIM1 and STIM2 in CD4+ T cells. CD4+ T cells lacking STIM1 and STIM2 were unable to provide “help” to CD8+ T cells due to aberrant regulation of CD40L expression. Together, our data indicate that STIM1, STIM2, and CRAC channel function play distinct but synergistic roles in CD4+ and CD8+ T cells during antiviral immunity.

Authors

Patrick J. Shaw, Carl Weidinger, Martin Vaeth, Kevin Luethy, Susan M. Kaech, Stefan Feske

×

Figure 3

STIM1 and STIM2 regulate CD8 memory in a non-CD8+ T cell–intrinsic manner.

Options: View larger image (or click on image) Download as PowerPoint
STIM1 and STIM2 regulate CD8 memory in a non-CD8+ T cell–intrinsic manne...
(A–E) Increased expression of cell death, proliferation, exhaustion, and memory differentiation markers in DKO CD8+ T cells after LCMVARM infection. WT and DKO mice were analyzed for the frequencies of apoptotic (annexin V+ in A), proliferating (Ki67+ in B), and exhausted (Tim-3+, PD-1+ in C) splenic CD8+ T cells. Line graphs show the mean ± SEM of all DbNP396–404 tetramer+ CD8+ T cells over the course of LCMV infection in WT and DKO mice (3–6 per group). (D) Impaired IL-2 and IFN-γ production by splenic DKO CD8+ T cells after in vitro stimulation with GP33–41 peptide for 6 hours. Representative dot plots (left) and mean percentages (right) of IL-2+ cells among IFN-γ+ CD8+ T cells. (E) T-bet and Eomes expression (ratio of MFI values) in DbNP396–404 tetramer+ CD8+ T cells from 3 WT and 3 DKO mice analyzed by flow cytometry. (F–K) Frequencies (F) and total numbers (G) of DbNP396–404 tetramer+ CD8+ T cells in 5 WT:DKO chimeras. Green boxes highlight memory CD8+ T cells. (H–J) Frequencies of apoptotic (annexin V+ in H), proliferating (Ki67+ in I), and exhausted (Tim-3+, PD-1+ in J) splenic memory CD8+ T cells of WT and DKO origin. (K) T-bet/Eomes ratio in memory CD8+ T cells from 5 WT:DKO chimeras. Statistical significance was calculated using Student’s t test (*P < 0.05; **P < 0.01; ***P < 0.001). Bar graphs show the means ± SEM. Numbers in D and F represent the percentages of cells in gates.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts